POZ - Latino Hub : Treatment News : HIV Conspiracy Theories Blunt Adherence in African-American Men

POZ Latino / Hispanic Hub
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:
 

Back to home » News & Views » Treatment News


 

March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007


emailrssprint

December 9, 2009

HIV Conspiracy Theories Blunt Adherence in African-American Men

Conspiracy theories about HIV—such as the belief that people who take antiretroviral (ARV) drugs are guinea pigs for the government—were associated with poorer adherence to ARV treatment in African-American HIV-positive men, according to a study published online December 1 in the Journal of Acquired Immune Deficiency Syndromes (JAIDS).

Numerous studies have documented that a significant proportion of HIV-positive African Americans hold misconceptions about the virus and its treatment, ultimately leading to mistrust of the government and the medical establishment when it comes to HIV. Such distrust is often tied to the history of the infamous Tuskegee study, conducted between 1932 and 1972, in which syphilis treatment was withheld from African-American men to study the effects of the disease.

To assess the impact of conspiracy beliefs in African-American men, Laura Bogart, PhD, from Harvard Medical School in Boston, and her colleagues recruited 214 HIV-positive African-American men. One-month follow-up data were available for 177 men, who were included in the final analysis. On average, the men had very low incomes, most identified barriers to health care, and only about 15 percent were employed. About 75 percent, however, had at least a 12th-grade education.

Bogart’s team surveyed both non-treatment-related and treatment-related beliefs held by the study participants. Non-treatment beliefs included: HIV is a manmade virus produced in a government laboratory and created and spread by the CIA, and/or the government created HIV to control the black population. Treatment-related beliefs included: The government is withholding the cure for HIV, people on ARVs are guinea pigs for the government, and ARV treatments are poison and even actually cause AIDS.

Nearly two thirds of the participants agreed with at least one of the conspiratorial statements about HIV, while 48 percent agreed with two or more. The most commonly held belief was that HIV was manmade. There was essentially no difference in income level or education between those who held conspiratorial beliefs and those who did not.

On average, the participants took only 68 percent of their prescribed doses, and less than 25 percent had optimum adherence. When adjusting the data to account for a variety of factors, such as education and income, treatment-related conspiratorial beliefs were associated with poor adherence, while more general non-treatment-related beliefs were not.

In closing, the authors write, “the prevalence of [HIV conspiracies] found in this and other studies…cannot be dismissed as rare or extreme. Such beliefs can ultimately contribute to decreased survival time (and further disparities) by discouraging appropriate treatment behavior. Adherence-promoting interventions that openly address and acknowledge HIV misconceptions, and identify and then target sources of misconceptions in communities, may contribute to overcoming such mistrust.”

NEW! Scroll down to comment on this story.

emailrssprint

 

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

  comments 1 - 2 (of 2 total)    

Oigen, , 2009-12-16 11:57:21
It's the fact that so called "HIV" is supposedly anywhere from ten to thirty times more prevalent in "African Americans" than any other race that they conclude that they are targeted by some government devil. Until the disparity among races can be explained then "HIV", is most likely simply a marker that manifests differently for different races for real medical afflictions and is therefore quite harmless as evidenced by the legions of people diagnosed with the supposed viral killer of all time

Dr Teddy, SFO, 2009-12-10 15:53:00
This is very true,I work for an AIDS social service organization targetting African Americans and these theories come up frequently. This can be tied to the evidence of high morbidity and mortality in the group even when access may be relatively available.

comments 1 - 2 (of 2 total)    


[Go to top]

Protesters hold the Hershey Company and its affiliated school accountable for condoning HIV-related discrimination. Click here to read more.
What to do if you've just been diagnosed
Qué hacer si eres recién diagnosticado

How to find a support system
Cómo encontrar un sistema de apoyo

Things you should know before starting treatment
Cosas que deberías saber antes de comenzar un tratamiento

How to handle side effects and other concerns
Cómo tratar los efectos secundarios y otros problemas de salud

How to tell someone you have HIV/AIDS
Cómo revelar tu diagnóstico de VIH/SIDA
[an error occurred while processing this directive]
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.